A Phase I Clinical Study for Evaluating the Safety of MASCT-I in Advanced Soild Tumor
Clinical trial NCT03393416 · UNKNOWN
Trial details
- NCT number
- NCT03393416
- Sponsor
- HRYZ Biotech Co.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-19
- Primary completion
- 2020-07-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.